Cancer Tumor Profiling Market Size, Share, Industry, Forecast and outlook (2023-2030)

North America holds the largest market share in the global Cancer Tumor Profiling market.

Major players are QIAGEN N.V, NeoGenomics Laboratories, Genomic Health Inc, Caris Life Sciences, Helomics Corporation, NanoString Technologies, Inc, Sysmex Corporation, Ribomed Biotechnologies, Inc, Roche Diagnostics and Illumina Inc.

The growth of the global Cancer Tumor Profiling market is driven by factors such as the growing incidence of cancer cases, increased funding for research and development activities, advancements in tumor profiling technologies, the acceptance of point-of-care diagnostics, and the rising demand for personalized medicines.

The Asia Pacific region is expected to be the fastest-growing market for Cancer Tumor Profiling due to factors such as increasing prevalence rates of cancer, a growing focus on preventive care, and government initiatives that promote technological innovations in the field. An example is the ongoing Molecular Profiling in Small Cell Lung Cancer project by Zhujiang Hospital, estimated to be completed by September 2021.